Medtronic Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Medtronic de 10.3% y 4.4% por año respectivamente. Se prevé que el BPA crezca en un 11.1% al año. Se espera que la rentabilidad financiera sea de 14.1% en 3 años.
Información clave
12.9%
Tasa de crecimiento de los beneficios
13.8%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Medical Equipment | 16.7% |
Tasa de crecimiento de los ingresos | 4.4% |
Rentabilidad financiera futura | 15.4% |
Cobertura de analistas | Good |
Última actualización | 04 Jun 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Medtronic: Dark Clouds Are Clearing - Outperformance Ahead
Aug 14Return Trends At Medtronic (NYSE:MDT) Aren't Appealing
Aug 11Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth
Jul 15Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?
Jul 09Is Medtronic (NYSE:MDT) A Risky Investment?
Jun 21Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter
Jun 21Is Medtronic's Dividend In A Good Place?
Jun 14Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69
Jun 03Medtronic: Solid Q4 Earnings, Don't Fret About Guidance
May 26Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
4/30/2027 | 36,729 | 5,997 | 6,778 | 9,000 | 18 |
4/30/2026 | 35,040 | 5,662 | 6,771 | 8,637 | 30 |
4/30/2025 | 33,416 | 4,993 | 6,540 | 8,009 | 30 |
4/26/2024 | 32,364 | 3,676 | 5,200 | 6,787 | N/A |
1/26/2024 | 32,320 | 4,201 | 4,931 | 6,470 | N/A |
10/27/2023 | 31,958 | 4,102 | 4,045 | 5,570 | N/A |
7/28/2023 | 31,558 | 3,620 | 4,444 | 5,831 | N/A |
4/28/2023 | 31,227 | 3,758 | 4,580 | 6,039 | N/A |
1/27/2023 | 30,771 | 4,064 | 4,166 | 5,636 | N/A |
10/28/2022 | 30,806 | 4,321 | 4,822 | 6,290 | N/A |
7/29/2022 | 31,070 | 5,205 | 5,721 | 7,137 | N/A |
4/29/2022 | 31,686 | 5,039 | 5,978 | 7,346 | N/A |
1/28/2022 | 31,785 | 4,914 | 5,678 | 7,034 | N/A |
10/29/2021 | 31,798 | 4,704 | 5,773 | 7,162 | N/A |
7/30/2021 | 31,597 | 3,882 | 5,855 | 7,254 | N/A |
4/30/2021 | 30,117 | 3,606 | 4,885 | 6,240 | N/A |
1/29/2021 | 27,926 | 2,892 | 4,631 | 5,945 | N/A |
10/30/2020 | 27,868 | 3,537 | 4,752 | 5,996 | N/A |
7/31/2020 | 27,927 | 4,412 | 4,756 | 6,002 | N/A |
4/24/2020 | 28,913 | 4,789 | 6,021 | 7,234 | N/A |
1/24/2020 | 31,062 | 5,408 | 6,659 | 7,871 | N/A |
10/25/2019 | 30,891 | 4,762 | 6,298 | 7,519 | N/A |
7/26/2019 | 30,666 | 4,420 | 5,671 | 6,815 | N/A |
4/26/2019 | 30,557 | 4,631 | 5,873 | 7,007 | N/A |
1/25/2019 | 30,555 | 4,826 | 4,867 | 5,958 | N/A |
10/26/2018 | 30,378 | 2,168 | 4,864 | 5,905 | N/A |
7/27/2018 | 29,947 | 3,163 | 4,568 | 5,649 | N/A |
4/27/2018 | 29,953 | 3,104 | 3,616 | 4,684 | N/A |
1/26/2018 | 29,725 | 2,859 | N/A | 5,419 | N/A |
10/27/2017 | 29,639 | 5,069 | N/A | 5,502 | N/A |
7/28/2017 | 29,934 | 4,115 | N/A | 6,067 | N/A |
4/28/2017 | 29,710 | 4,028 | N/A | 6,880 | N/A |
1/27/2017 | 29,361 | 3,968 | N/A | 6,433 | N/A |
10/28/2016 | 29,012 | 4,242 | N/A | 6,145 | N/A |
7/29/2016 | 28,725 | 3,647 | N/A | 5,952 | N/A |
4/29/2016 | 28,833 | 3,538 | N/A | 5,218 | N/A |
1/29/2016 | 28,435 | 2,434 | N/A | 5,804 | N/A |
10/30/2015 | 25,819 | 2,316 | N/A | 5,774 | N/A |
7/31/2015 | 23,127 | 2,624 | N/A | 5,408 | N/A |
4/24/2015 | 20,261 | 2,675 | N/A | 4,902 | N/A |
1/23/2015 | 17,410 | 3,124 | N/A | 4,318 | N/A |
10/24/2014 | 17,255 | 2,909 | N/A | 4,163 | N/A |
7/25/2014 | 17,083 | 2,983 | N/A | 4,286 | N/A |
4/25/2014 | 16,893 | 3,065 | N/A | 4,959 | N/A |
1/24/2014 | 16,879 | 3,586 | N/A | 4,901 | N/A |
10/25/2013 | 16,743 | 3,812 | N/A | 4,735 | N/A |
7/26/2013 | 16,644 | 3,556 | N/A | 4,593 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (10.3% al año) de MDT es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (10.3% al año) de MDT crezcan menos que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de MDT crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (4.4% al año) de MDT crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 4.4% al año) de MDT crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de MDT sea baja dentro de 3 años (14.1%).